511 results on '"Itoh, Hideki"'
Search Results
2. A Clinical Trial Evaluating the Efficacy of Deep Learning-Based Facial Recognition for Patient Identification in Diverse Hospital Settings
3. Extracorporeal membrane oxygenation for the anesthetic management of a patient with severe airway stenosis caused by thyroid carcinoma invasion
4. Efficacy and Tolerability of Ivabradine for Cardiomyopathy in Patients with Duchenne Muscular Dystrophy
5. Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation
6. Acquired Long QT Syndrome and Torsades de Pointes
7. Novel CALM3 Variant Causing Calmodulinopathy With Variable Expressivity in a 4-Generation Family
8. Cardiac Involvements in Myotonic Dystrophy
9. qMaLioffG: A single green fluorescent protein FLIM indicator enabling quantitative imaging of endogenous ATP
10. Neonatal Wnt-dependent Lgr5 positive stem cells are essential for uterine gland development
11. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
12. Impact of Updated Diagnostic Criteria for Long QT Syndrome on Clinical Detection of Diseased Patients: Results From a Study of Patients Carrying Gene Mutations
13. Population Pharmacokinetics and Pharmacodynamics of Apixaban Linking Its Plasma Concentration to Intrinsic Activated Coagulation Factor X Activity in Japanese Patients with Atrial Fibrillation
14. Novel CACNA1C R511Q mutation, located in domain Ⅰ-Ⅱ linker, causes non-syndromic type-8 long QT syndrome
15. Safety and efficacy of combined sedation with dexmedetomidine and midazolam for endoscopic retrograde cholangiopancreatography in patients over 80 years of age
16. Impact of ABCB1, ABCG2, and CYP3A5 polymorphisms on plasma trough concentrations of apixaban in Japanese patients with atrial fibrillation
17. Arrhythmia risk and β-blocker therapy in pregnant women with long QT syndrome
18. Cardiac Involvement of Myotonic Dystrophy
19. Carvedilol, a Non-Selective β-with α1-Blocker is Effective in Long QT Syndrome Type 2
20. The genetics underlying acquired long QT syndrome: impact for genetic screening
21. High prevalence of early repolarization in short QT syndrome
22. KCNE2 modulation of Kv4.3 current and its potential role in fatal rhythm disorders
23. Differences in Pharmaceutical Intervention Triggers for the Optimization of Medication by Patient Age: A University Hospital Study
24. Microscopic heat pulses activate cardiac thin filaments
25. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
26. Long QT syndrome type 8: novel CACNA1C mutations causing QT prolongation and variant phenotypes
27. Exon 3 deletion of RYR2 encoding cardiac ryanodine receptor is associated with left ventricular non-compaction
28. A Novel SCN5A Gain-of-Function Mutation M1875T Associated With Familial Atrial Fibrillation
29. Hydroxyzine, a First Generation H1-Receptor Antagonist, Inhibits Human Ether-a-go-go–Related Gene (HERG) Current and Causes Syncope in a Patient With the HERG Mutation
30. Differential effects of isoflurane on A-type and delayed rectifier K channels in rat substantia nigra
31. Gain-of-Function KCNH2 Mutations in Patients with Brugada Syndrome
32. Cardiac Channelopathies Associated with Infantile Fatal Ventricular Arrhythmias: From the Cradle to the Bench
33. JCS/JHRS2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias
34. Corrigendum to “A challenge for mutation specific risk stratification in long QT syndrome type 1” [J. Cardiol. 72(1) (2018) 56–65]
35. High incidence of major bleeding with off-label use of edoxaban
36. Enhancing rare variant interpretation in inherited arrhythmias through quantitative analysis of consortium disease cohorts and population controls
37. The E1784K mutation in SCN5A is associated with mixed clinical phenotype of type 3 long QT syndrome
38. Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome
39. N- and C-terminal KCNE1 mutations cause distinct phenotypes of long QT syndrome
40. A paradoxical effect of lidocaine for the N406S mutation of SCN5A associated with Brugada syndrome
41. Bradycardia Is a Specific Phenotype of Catecholaminergic Polymorphic Ventricular Tachycardia Induced by RYR2 Mutations
42. Genetic Background of Catecholaminergic Polymorphic Ventricular Tachycardia in Japan
43. Age-Dependent Clinical and Genetic Characteristics in Japanese Patients with Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia
44. Numerical analysis of relative humidity distribution in polymer electrolyte fuel cell stack including cooling water
45. Effect of flow pattern of gas and cooling water on relative humidity distribution in polymer electrolyte fuel cell
46. Septal wall thinning and systolic dysfunction in patients with hypertrophic cardiomyopathy caused by a cardiac troponin I gene mutation
47. A novel gain-of-function KCNJ2 mutation associated with short-QT syndrome impairs inward rectification of Kir2.1 currents
48. Mechanisms of modulation of neuronal nicotinic receptors by substance P and OAG
49. Increased QT dispersion does not reflect the increased regional variation of cardiac sympathetic nervous activity in hypertrophic cardiomyopathy
50. A computational analysis of the effect of sevoflurane in a human ventricular cell model of long QT syndrome: Importance of repolarization reserve in the QT-prolonging effect of sevoflurane
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.